Dr. Mathew M. Cannava, MD

Dr. Cannava practices at The Dermatology And Skin Cancer Clinic Of Alaska in Soldotna, Alaska.

Dr. Cannava's NPI, 1245368695, was assigned on February 28, 2007. Dr. Cannava graduated from George Washington University School of Medicine in 1997. Dr. Cannava holds Alaska license AK4179.

Dr. Cannava's primary practice is The Dermatology and Skin Cancer Clinic of Alaska, at 180 E Beluga Ave, Soldotna, AK 99669. The practice phone is (907) 262-7546.

Dr. Cannava's primary practice is The Dermatology And Skin Cancer Clinic Of Alaska in Soldotna, Alaska. The medical group on file is The Dermatology and Skin Cancer Clinic of Alaska.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cannava practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Cannava's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Cannava is licensed in Alaska.

CMS data shows 1,957 Medicare services from Dr. Cannava across 17 procedure codes in 2024, for 605 Medicare patients. Medicare paid $158,606 for them. Every service was in an office.

CMS counts 605 Medicare patients who saw Dr. Cannava in 2024. The largest group is 65 to 74, with 277 patients. 61% of them have high blood pressure, and 61% have high cholesterol. 9% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cannava's median patient age at 77, with 44% women.

In 2024, Dr. Cannava wrote 391 Medicare Part D claims for 172 patients. 90% of them were for generic drugs. CMS names the drug for 289 of them, across 10 drugs with 11 or more claims each, at $230,508 in total drug cost. In 2023, CMS named 335 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 50 out of 100 for Dr. Cannava for performance year 2024, reported individually. Dr. Cannava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 99 procedures of melanoma (skin cancer) excision by Dr. Cannava, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 13 general payments to Dr. Cannava from 7 drug and device companies from 2016 to 2018. Gifts make up the largest share, 80% of the total. ZO Skin Health, Inc. paid the most, $855.

Dr. Cannava graduated from George Washington University School of Medicine in 1997.